サマリー

ロサルタン／ヒドロクロロチアジドは、2つの薬剤を1つの製剤にしたものです。高血圧の治療に使用されます。また、高血圧と左心室肥大と呼ばれる心臓病を持つ人の脳卒中のリスクを減らすためにも使用されます。

市場分析と洞察。世界と日本のロサルタンとヒドロクロロチアジドの錠剤市場
本レポートでは、世界と日本のロサルタンとヒドロクロロチアジド錠市場に焦点を当てています。
2020年のロサルタンとヒドロクロロチアジド錠の世界市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、ロサルタンおよびヒドロクロロチアジド錠の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルになると予測され、予測期間中にXX％のCAGRで成長すると見込まれています。

ロサルタン・ヒドロクロロチアジド錠の世界的な規模と市場規模
ロサルタン・ヒドロクロロチアジド錠市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。ロサルタンとヒドロクロロチアジド錠の世界市場に参加するプレイヤー、ステークホルダーなどは、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場では、2016-2027年のロサルタンおよびヒドロクロロチアジド錠の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
50 mg/ 12.5 mg
100 mg/ 25 mg

用途別セグメント
病院
クリニック
リカバリーセンター

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
アレンビック
カディスタ
ルパン
ライジング・ファーマシューティカルズ
Sandoz
テバ
メルク
トレント
オーロビンド

ページTOPに戻る

目次

1 Study Coverage
1.1 Losartan and Hydrochlorothiazide Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Losartan and Hydrochlorothiazide Tablets Market Size Growth Rate by Type
1.2.2 50 mg/ 12.5 mg
1.2.3 100 mg/ 25 mg
1.3 Market by Application
1.3.1 Global Losartan and Hydrochlorothiazide Tablets Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Losartan and Hydrochlorothiazide Tablets Market Size, Estimates and Forecasts
2.1.1 Global Losartan and Hydrochlorothiazide Tablets Revenue 2016-2027
2.1.2 Global Losartan and Hydrochlorothiazide Tablets Sales 2016-2027
2.2 Global Losartan and Hydrochlorothiazide Tablets, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Losartan and Hydrochlorothiazide Tablets Historical Market Size by Region (2016-2021)
2.3.1 Global Losartan and Hydrochlorothiazide Tablets Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Losartan and Hydrochlorothiazide Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Losartan and Hydrochlorothiazide Tablets Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Losartan and Hydrochlorothiazide Tablets Sales Forecast by Region (2022-2027)
2.4.2 Global Losartan and Hydrochlorothiazide Tablets Revenue Forecast by Region (2022-2027)

3 Global Losartan and Hydrochlorothiazide Tablets Competitor Landscape by Players
3.1 Global Top Losartan and Hydrochlorothiazide Tablets Manufacturers by Sales
3.1.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Manufacturer (2016-2021)
3.1.2 Global Losartan and Hydrochlorothiazide Tablets Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Losartan and Hydrochlorothiazide Tablets Manufacturers by Revenue
3.2.1 Key Losartan and Hydrochlorothiazide Tablets Manufacturers Covered: Ranking by Revenue
3.2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Manufacturers (2016-2021)
3.2.3 Global Losartan and Hydrochlorothiazide Tablets Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Losartan and Hydrochlorothiazide Tablets Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Losartan and Hydrochlorothiazide Tablets Revenue in 2020
3.2.6 Global Losartan and Hydrochlorothiazide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Losartan and Hydrochlorothiazide Tablets Price by Manufacturers
3.4 Global Losartan and Hydrochlorothiazide Tablets Manufacturing Base Distribution, Product Types
3.4.1 Losartan and Hydrochlorothiazide Tablets Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Losartan and Hydrochlorothiazide Tablets Product Type
3.4.3 Date of International Manufacturers Enter into Losartan and Hydrochlorothiazide Tablets Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Losartan and Hydrochlorothiazide Tablets Market Size by Type (2016-2021)
4.1.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Type (2016-2021)
4.1.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Type (2016-2021)
4.1.3 Losartan and Hydrochlorothiazide Tablets Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Losartan and Hydrochlorothiazide Tablets Market Size Forecast by Type (2022-2027)
4.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales Forecast by Type (2022-2027)
4.2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue Forecast by Type (2022-2027)
4.2.3 Losartan and Hydrochlorothiazide Tablets Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Losartan and Hydrochlorothiazide Tablets Market Size by Application (2016-2021)
5.1.1 Global Losartan and Hydrochlorothiazide Tablets Sales by Application (2016-2021)
5.1.2 Global Losartan and Hydrochlorothiazide Tablets Revenue by Application (2016-2021)
5.1.3 Losartan and Hydrochlorothiazide Tablets Price by Application (2016-2021)
5.2 Losartan and Hydrochlorothiazide Tablets Market Size Forecast by Application (2022-2027)
5.2.1 Global Losartan and Hydrochlorothiazide Tablets Sales Forecast by Application (2022-2027)
5.2.2 Global Losartan and Hydrochlorothiazide Tablets Revenue Forecast by Application (2022-2027)
5.2.3 Global Losartan and Hydrochlorothiazide Tablets Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
6.1.1 Japan Losartan and Hydrochlorothiazide Tablets Sales YoY Growth 2016-2027
6.1.2 Japan Losartan and Hydrochlorothiazide Tablets Revenue YoY Growth 2016-2027
6.1.3 Japan Losartan and Hydrochlorothiazide Tablets Market Share in Global Market 2016-2027
6.2 Japan Losartan and Hydrochlorothiazide Tablets Market Size by Players (International and Local Players)
6.2.1 Japan Top Losartan and Hydrochlorothiazide Tablets Players by Sales (2016-2021)
6.2.2 Japan Top Losartan and Hydrochlorothiazide Tablets Players by Revenue (2016-2021)
6.3 Japan Losartan and Hydrochlorothiazide Tablets Historic Market Review by Type (2016-2021)
6.3.1 Japan Losartan and Hydrochlorothiazide Tablets Sales Market Share by Type (2016-2021)
6.3.2 Japan Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Type (2016-2021)
6.3.3 Japan Losartan and Hydrochlorothiazide Tablets Price by Type (2016-2021)
6.4 Japan Losartan and Hydrochlorothiazide Tablets Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Losartan and Hydrochlorothiazide Tablets Sales Forecast by Type (2022-2027)
6.4.2 Japan Losartan and Hydrochlorothiazide Tablets Revenue Forecast by Type (2022-2027)
6.4.3 Japan Losartan and Hydrochlorothiazide Tablets Price Forecast by Type (2022-2027)
6.5 Japan Losartan and Hydrochlorothiazide Tablets Historic Market Review by Application (2016-2021)
6.5.1 Japan Losartan and Hydrochlorothiazide Tablets Sales Market Share by Application (2016-2021)
6.5.2 Japan Losartan and Hydrochlorothiazide Tablets Revenue Market Share by Application (2016-2021)
6.5.3 Japan Losartan and Hydrochlorothiazide Tablets Price by Application (2016-2021)
6.6 Japan Losartan and Hydrochlorothiazide Tablets Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Losartan and Hydrochlorothiazide Tablets Sales Forecast by Application (2022-2027)
6.6.2 Japan Losartan and Hydrochlorothiazide Tablets Revenue Forecast by Application (2022-2027)
6.6.3 Japan Losartan and Hydrochlorothiazide Tablets Price Forecast by Application (2022-2027)

7 North America
7.1 North America Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
7.2 North America Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country
7.2.1 North America Losartan and Hydrochlorothiazide Tablets Sales by Country (2016-2021)
7.2.2 North America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
8.2 Asia Pacific Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Region
8.2.1 Asia Pacific Losartan and Hydrochlorothiazide Tablets Sales by Region (2016-2021)
8.2.2 Asia Pacific Losartan and Hydrochlorothiazide Tablets Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
9.2 Europe Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country
9.2.1 Europe Losartan and Hydrochlorothiazide Tablets Sales by Country (2016-2021)
9.2.2 Europe Losartan and Hydrochlorothiazide Tablets Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
10.2 Latin America Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country
10.2.1 Latin America Losartan and Hydrochlorothiazide Tablets Sales by Country (2016-2021)
10.2.2 Latin America Losartan and Hydrochlorothiazide Tablets Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Market Facts & Figures by Country
11.2.1 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Sales by Country (2016-2021)
11.2.2 Middle East and Africa Losartan and Hydrochlorothiazide Tablets Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Alembic
12.1.1 Alembic Corporation Information
12.1.2 Alembic Description and Business Overview
12.1.3 Alembic Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Alembic Losartan and Hydrochlorothiazide Tablets Products Offered
12.1.5 Alembic Recent Development
12.2 Cadista
12.2.1 Cadista Corporation Information
12.2.2 Cadista Description and Business Overview
12.2.3 Cadista Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cadista Losartan and Hydrochlorothiazide Tablets Products Offered
12.2.5 Cadista Recent Development
12.3 Lupin
12.3.1 Lupin Corporation Information
12.3.2 Lupin Description and Business Overview
12.3.3 Lupin Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Lupin Losartan and Hydrochlorothiazide Tablets Products Offered
12.3.5 Lupin Recent Development
12.4 Rising Pharmaceuticals
12.4.1 Rising Pharmaceuticals Corporation Information
12.4.2 Rising Pharmaceuticals Description and Business Overview
12.4.3 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Rising Pharmaceuticals Losartan and Hydrochlorothiazide Tablets Products Offered
12.4.5 Rising Pharmaceuticals Recent Development
12.5 Sandoz
12.5.1 Sandoz Corporation Information
12.5.2 Sandoz Description and Business Overview
12.5.3 Sandoz Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sandoz Losartan and Hydrochlorothiazide Tablets Products Offered
12.5.5 Sandoz Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Description and Business Overview
12.6.3 Teva Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Losartan and Hydrochlorothiazide Tablets Products Offered
12.6.5 Teva Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Description and Business Overview
12.7.3 Merck Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Losartan and Hydrochlorothiazide Tablets Products Offered
12.7.5 Merck Recent Development
12.8 Torrent
12.8.1 Torrent Corporation Information
12.8.2 Torrent Description and Business Overview
12.8.3 Torrent Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Torrent Losartan and Hydrochlorothiazide Tablets Products Offered
12.8.5 Torrent Recent Development
12.9 Aurobindo
12.9.1 Aurobindo Corporation Information
12.9.2 Aurobindo Description and Business Overview
12.9.3 Aurobindo Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo Losartan and Hydrochlorothiazide Tablets Products Offered
12.9.5 Aurobindo Recent Development
12.11 Alembic
12.11.1 Alembic Corporation Information
12.11.2 Alembic Description and Business Overview
12.11.3 Alembic Losartan and Hydrochlorothiazide Tablets Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Alembic Losartan and Hydrochlorothiazide Tablets Products Offered
12.11.5 Alembic Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Losartan and Hydrochlorothiazide Tablets Industry Trends
13.2 Losartan and Hydrochlorothiazide Tablets Market Drivers
13.3 Losartan and Hydrochlorothiazide Tablets Market Challenges
13.4 Losartan and Hydrochlorothiazide Tablets Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Losartan and Hydrochlorothiazide Tablets Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer